ALK-Abelló raises 2025 outlook after strong Q3, shares jump 11%

Published 13/11/2025, 11:26
ALK-Abelló raises 2025 outlook after strong Q3, shares jump 11%

Investing.com -- ALK-Abelló has raised its financial expectations for 2025 following strong performance in the third quarter and a positive outlook for the remainder of the year.

The company now expects revenue growth of 13-15% in local currencies, up from its previous forecast of 12-14%. Additionally, ALK-Abelló has increased its projected EBIT margin to approximately 26%, compared to the earlier estimate of 25%.

According to the company, the improved revenue growth will be driven by "higher volumes, as ALK expects to treat more patients with the company’s allergy immunotherapy and anaphylaxis products."

The market responded positively to the upgraded outlook, with ALK-Abelló shares rising 11% on Thursday.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.